Table 3.

BCON patient clinicopathologic features by randomization arm

RTRT+CON
Variablen = 97n = 88P
Gender0.48
 Male73 (75.3%)71 (80.7%)
 Female24 (24.7%)17 (19.3%)
Age, y75.0 (51.5–89.7)75.1 (51.5–90.5)0.83
T Stage0.63
 T14 (4.1%)4 (4.5%)
 T276 (78.4%)70 (79.6%)
 T316 (16.5%)11 (12.5%)
 T4a1 (1.0%)3 (3.4%)
Necrosis0.19
 Absent48 (49.5%)53 (60.2%)
 Present49 (50.5%)35 (39.8%)
Concurrent pTis0.002
 Absent30 (30.9%)10 (11.4%)
 Present67 (69.1%)78 (88.6%)
Hb (g/L)13.7 (9.3–17.0)14.1 (9.8–17.2)0.46
 No data10
TLDA-HS0.022 (4 × 10−4 to 0.148)0.019 (3 × 10−4 to 0.062)0.37
Percent tumor80% (15–95%)80% (30–100%)0.34

NOTE: Data are represented as n (%) or median (range).

Abbreviations: Hb, hemoglobin; RT, radiotherapy.